01873.HK
Viva Biotech Holdings
HKSE · Healthcare · Biotechnology · CN
HKD 1.25
−1.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 8.36x
- P/E 2027E
- 6.27x
- P/E 2028E
- —
- P/S forward
- 2.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.95x
- PEG TTM
- —
- Price / book
- 0.57x
- Price / sales
- 1.19x
- Price / cash flow
- 5.25x
Enterprise value
- Enterprise value
- HKD 2.5B
- EV / sales
- 1.11x
- EV / EBITDA
- 5.33x
- EV / EBIT
- 11.02x
- Market cap
- HKD 2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026